A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCAVONE, Cristoforo et al. Repeated predictable or unpredictable stress effects on NF-kB in central nervous system (CNS). The Pharmacologist, v. 44, n. 2, p. 109, 2002Tradução . . Acesso em: 09 set. 2024.
APA
Scavone, C., Silva, M. C. C. de S., Glezer, I., Munhoz, C. D., Lucia, R. de, Kawamoto, E. M., & Planeta, C. da S. (2002). Repeated predictable or unpredictable stress effects on NF-kB in central nervous system (CNS). The Pharmacologist, 44( 2), 109.
NLM
Scavone C, Silva MCC de S, Glezer I, Munhoz CD, Lucia R de, Kawamoto EM, Planeta C da S. Repeated predictable or unpredictable stress effects on NF-kB in central nervous system (CNS). The Pharmacologist. 2002 ; 44( 2): 109.[citado 2024 set. 09 ]
Vancouver
Scavone C, Silva MCC de S, Glezer I, Munhoz CD, Lucia R de, Kawamoto EM, Planeta C da S. Repeated predictable or unpredictable stress effects on NF-kB in central nervous system (CNS). The Pharmacologist. 2002 ; 44( 2): 109.[citado 2024 set. 09 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Cilene R R. e DELUCIA, Roberto e SILVA, Maria Teresa de Araújo. Effects of fencamfamine on latent inhibition. Progress in Neuro-Psychopharmacology & Biological Psychiatry, v. 26, p. 1089-1093, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0278-5846(02)00241-5. Acesso em: 09 set. 2024.
APA
Alves, C. R. R., Delucia, R., & Silva, M. T. de A. (2002). Effects of fencamfamine on latent inhibition. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26, 1089-1093. doi:10.1016/s0278-5846(02)00241-5
NLM
Alves CRR, Delucia R, Silva MT de A. Effects of fencamfamine on latent inhibition [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2002 ; 26 1089-1093.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/s0278-5846(02)00241-5
Vancouver
Alves CRR, Delucia R, Silva MT de A. Effects of fencamfamine on latent inhibition [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2002 ; 26 1089-1093.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/s0278-5846(02)00241-5
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORRES, M A W e SUENAGA, E M e YASAKA, W J. Correlation between pharmacological behavioral effects and pharmacokinetics parameters of bromazepan in mice. Medsul 99, p. 31, 1999Tradução . . Acesso em: 09 set. 2024.
APA
Torres, M. A. W., Suenaga, E. M., & Yasaka, W. J. (1999). Correlation between pharmacological behavioral effects and pharmacokinetics parameters of bromazepan in mice. Medsul 99, 31.
NLM
Torres MAW, Suenaga EM, Yasaka WJ. Correlation between pharmacological behavioral effects and pharmacokinetics parameters of bromazepan in mice. Medsul 99. 1999 ; 31.[citado 2024 set. 09 ]
Vancouver
Torres MAW, Suenaga EM, Yasaka WJ. Correlation between pharmacological behavioral effects and pharmacokinetics parameters of bromazepan in mice. Medsul 99. 1999 ; 31.[citado 2024 set. 09 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VITAL, Maria Aparecida Barbato Frazão et al. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. Life Sciences, v. 62, n. 13, p. 1161-1169, 1998Tradução . . Disponível em: https://doi.org/10.1016/S0024-3205(98)00042-3. Acesso em: 09 set. 2024.
APA
Vital, M. A. B. F., Flório, J. C., Frussa-Filho, R., De Lucia, R., Tufik, S., & Palermo-Neto, J. (1998). Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. Life Sciences, 62( 13), 1161-1169. doi:10.1016/S0024-3205(98)00042-3
NLM
Vital MABF, Flório JC, Frussa-Filho R, De Lucia R, Tufik S, Palermo-Neto J. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover [Internet]. Life Sciences. 1998 ; 62( 13): 1161-1169.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/S0024-3205(98)00042-3
Vancouver
Vital MABF, Flório JC, Frussa-Filho R, De Lucia R, Tufik S, Palermo-Neto J. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover [Internet]. Life Sciences. 1998 ; 62( 13): 1161-1169.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/S0024-3205(98)00042-3
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELUCIA, Roberto et al. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rats. Biological clocks: mechanism and applications. Tradução . New York: Elsevier, 1998. . . Acesso em: 09 set. 2024.
APA
DeLucia, R., Planeta, C. S., Ferreira, M. P., Aizenstein, M. L., & Scavone, C. (1998). Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rats. In Biological clocks: mechanism and applications. New York: Elsevier.
NLM
DeLucia R, Planeta CS, Ferreira MP, Aizenstein ML, Scavone C. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rats. In: Biological clocks: mechanism and applications. New York: Elsevier; 1998. [citado 2024 set. 09 ]
Vancouver
DeLucia R, Planeta CS, Ferreira MP, Aizenstein ML, Scavone C. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rats. In: Biological clocks: mechanism and applications. New York: Elsevier; 1998. [citado 2024 set. 09 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PLANETA, C S e AIZENSTEIN, Moacyr Luiz e DE LUCIA, R. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors. Pharmacology Biochemistry and Behavior, v. 50, n. 1 , p. 35-40, 1995Tradução . . Disponível em: https://doi.org/10.1016/0091-3057(94)00236-c. Acesso em: 09 set. 2024.
APA
Planeta, C. S., Aizenstein, M. L., & De Lucia, R. (1995). Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors. Pharmacology Biochemistry and Behavior, 50( 1 ), 35-40. doi:10.1016/0091-3057(94)00236-c
NLM
Planeta CS, Aizenstein ML, De Lucia R. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors [Internet]. Pharmacology Biochemistry and Behavior. 1995 ;50( 1 ): 35-40.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/0091-3057(94)00236-c
Vancouver
Planeta CS, Aizenstein ML, De Lucia R. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors [Internet]. Pharmacology Biochemistry and Behavior. 1995 ;50( 1 ): 35-40.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/0091-3057(94)00236-c
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE LUCIA, R et al. Daily variation in plasma concentration of fencamfamine and striatal dopamine receptor in rats. 1994, Anais.. Amelia: Instituto de Ciências Biomédicas, Universidade de São Paulo, 1994. . Acesso em: 09 set. 2024.
APA
De Lucia, R., Planeta, C. S., Aizenstein, M. L., & Oliveira, G. H. (1994). Daily variation in plasma concentration of fencamfamine and striatal dopamine receptor in rats. In Program and Abstracts. Amelia: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
De Lucia R, Planeta CS, Aizenstein ML, Oliveira GH. Daily variation in plasma concentration of fencamfamine and striatal dopamine receptor in rats. Program and Abstracts. 1994 ;[citado 2024 set. 09 ]
Vancouver
De Lucia R, Planeta CS, Aizenstein ML, Oliveira GH. Daily variation in plasma concentration of fencamfamine and striatal dopamine receptor in rats. Program and Abstracts. 1994 ;[citado 2024 set. 09 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PLANETA, C S et al. Daily variation in plasma concentrations of fencamfamine in rats. 1993, Anais.. Quebec: Instituto de Ciências Biomédicas, Universidade de São Paulo, 1993. . Acesso em: 09 set. 2024.
APA
Planeta, C. S., De Lucia, R., Aizenstein, M. L., & Oliveira, G. H. (1993). Daily variation in plasma concentrations of fencamfamine in rats. In Abstracts and Program. Quebec: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Planeta CS, De Lucia R, Aizenstein ML, Oliveira GH. Daily variation in plasma concentrations of fencamfamine in rats. Abstracts and Program. 1993 ;[citado 2024 set. 09 ]
Vancouver
Planeta CS, De Lucia R, Aizenstein ML, Oliveira GH. Daily variation in plasma concentrations of fencamfamine in rats. Abstracts and Program. 1993 ;[citado 2024 set. 09 ]
